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randomized between dose-escalation of the entire primary tumour or 
to the high FDG uptake region inside the primary tumour. Plans are 
normalized to the same mean lung dose, while giving 66 Gy in 24 
fractions to involved lymph nodes. The trial has already accrued 66 
patients and will soon be extended to five participating centres. The 
head and neck trial investigates the impact of delivering a high 
radiation dose to the most active part of the tumour, as seen on the 
PET-CT scan by adaptive radiotherapy. Patients are randomized 
between a conventional IMRT and adaptive IMRT by redistribution of 
the radiation dose: with higher doses given to the most active part of 
the tumour and low doses at the border of the CTV. In the adaptive 
arm, the treatment plan is modified to account for anatomical 
changes occurring over the course of therapy. In a factorial design, 
patients are randomized between 1) conventional and adaptive 
radiotherapy and 2) radiotherapy plus cisplatin or cetuximab. The 
sensitivity for cisplatin and cetuximab is estimated by both molecular 
profiling research and the 3D measurement of 89- Zirconium uptake in 
the tumour. The first patient just completed the treatment with the 
combination of radiotherapy and cetuximab in the head and neck 
cancer study. Although this is a very sophisticated and intensive 
approach, the treatment has proceeded without problems. 
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There is growing concern about the possible long-term risks to 
radiotherapy patients from neutrons, which are generated as a by-
product either in high-energy photon beams, or proton beams.  The 
usual approach to estimating the risk from neutrons is to use ICRP risk 
factors and radiation weighting factors for neutrons.  There are a 
number of problems with this, and indeed the ICRP state clearly that 
their numbers are approximations, which should only be used for 
radiation protection guidelines, and not for individuals.  According to 
the ICRP scheme, the risk from neutrons is determined by means of 
the relative biological effectiveness (RBE) of neutrons compared to 
photons for which the risks are better known.  However there is 
considerable uncertainty about how RBE for neutrons varies with dose 
and neutron energy, or whether the RBE model is even appropriate.  
Two major reasons for this are that it is very difficult to obtain risk 
data in exposure situations where the neutron energy is confined to a 
narrow spectrum (or even well known), and the occurrence of risk 
events at the low doses of interest is very low giving poor statistics.  
Previous research on risks from neutron risk has mainly been single-
discipline.  That is, the results have been dependent on a single 
experimental or epidemiological approach.  By contrast, the ANDANTE 
project uses three different disciplines in parallel.  This is analogous 
to taking images of an object using three different imaging modalities 
and combining them to produce an image much sharper than any of 
the individual images.  The three parallel approaches are: 
Physics: a track structure model is used to contrast the patterns of 
damage to cellular macro-molecules from neutrons compared to 
photons.  The simulations reproduce the same energy spectra as are 
used in the other two approaches. 
Stem cell radiobiology: stem cells from thyroid, salivary gland, and 
breast tissue are given well characterised exposures to neutrons and 
photons.  A number of endpoints are used to estimate the relative risk 
of damage from neutrons compared to photons.  As well, irradiated 
cells will be transplanted into mice to investigate the incidence of 
progression into tumours.   
Epidemiology: the relative incidence rates of second cancers of the 
thyroid, salivary gland, and breast following paediatric radiotherapy 
(conventional radiotherapy for photons and proton therapy for 
neutrons) are investigated in a pilot single-institution study, leading to 
a multi-institution prospective study. 
The project has completed the first of its four years.  Progress on 
characterising the exposure beams, isolation and initial exposures of 
stem cells, and data collection for the epidemiological studies will be 
presented.  
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Out-of field neutron exposure of proton therapy might lead to 
enhanced formation of second cancer. The goal of the Andante 
project is to estimate the risk of second cancer from out-of field 
neutron exposure and compare this with other treatment modalities. 
This study focuses on two specific cancers that may be detected as 
second malignant neoplasms following pediatric radiotherapy:salivary 
gland and thyroid gland cancer. It has been suggested that adult stem 
cells are a critical target for radiation carcinogenesis. Therefore, in 
this study adult stem cells from murine salivary and thyroid glands 
were isolated and expanded in culture. Stem cell containing spheroids 
(multicellular 3D structures) could be obtained from both murine 
salivary and thyroid glands in non-adherent cultivation of cell 
suspensions of salivary and thyroid gland tissue in serum-free 
conditions. After digestion of spheroids into single cells, cells were 
exposed to different doses (0.1, 0.5, 1, 2, 5 Gy) of ϒ-irradiation. To 
determine transformation, in vitro self-renewal and differentiation 
capacity were investigated of irradiated cells and were compared to 
unirradiated cells. In addition, salivary and thyroid cells were isolated 
from inducible p53 knockout mice to test the carcinogenesis potential 
of the model. Transplantation of irradiated stem cells in photon-
irradiated salivary glands will be performed to get information on 
carcinogenic transformation in vivo. In the future, stem cells will be 
exposed to neutrons and will be compared to the exposure of photons.  
   
 POSTER DISCUSSION: 6: PHYSICS: DOSE MEASURE-
MENTS  
  
PD-0225   
IMRT credentialing for prospective trials using institutional 
phantoms: Results of a joint EORTC and RPC project. 
D.C. Weber1, V. Vallet2, A. Molineu3, C. Melidis4, V. Teglas4, R. 
Moekli2, D.S. Followill3, C.W. Hurkmans5 
1Hôpital Cantonal Univ. Genève, Radiation Oncology, Geneva 14, 
Switzerland  
2Lausanne University Hospital, Institute of Radiation Physics, 
Lausanne, Switzerland  
3The University of Texas M. D. Anderson Cancer Center, Department 
of Radiation Physics, Houston TX, USA  
4EORTC HQ, QART team, Brussels, Belgium  
5Catharina Hospital, Department of Radiation Oncology, Eindhoven, 
The Netherlands  
 
Purpose/Objective: Intensity-modulated radiotherapy (IMRT) 
credentialing for the 22074-24071 Head and Neck (H&N) EORTC study 
was performed using the anthropomorphic head phantom from the 
Radiological Physics Center (RPC; RPCph). Institutions were also 
retrospectively requested to irradiate their own in-house phantom 
(Instph) using the same treatment plan in the framework of a Virtual 
Phantom Project (VPP) for IMRT credentialing. Both measurement and 
calculations for the RPCph and Instph were sent to the EORTC for 
central analysis using the digital quality assurance (QA) platform. 
Materials and Methods: Calculated and measured 2D dose matrices on 
the Instph were requested from centers and send to a dedicated 
secured EORTC uploader. RPC analyzed the credentialing 
measurements performed in the RPCph using the VPP metrics. Data 
from the RPCph and INSTph were thereafter centrally analyzed and 
inter-compared by the QA team using commercially available 
software. 
Results: Eighteen institutions participated to the VPP. The 
measurements of 6 (33%) institutions could not be analyzed centrally, 
as a result of incomplete datasets (n=4) or dose-matrix format issues 
(n=2). All other centers (n=12; 66%) could be credentialed successfully 
using the VPP protocol and the dose-gradient produced by the IMRT 
plans were acceptable in all cases using the RPC criteria. The same 
number of institutions (n=12) was successfully credentialed using the 
more stringent 5%/5 mm pass at the 90% pixel cutoff-level gamma 
analysis criteria. A passing rate of 84.8±13.1%, 97.8±3.2% and 
99.3±1.2% for the 3%/3 mm,5%/5 mm and 7%/4mm QA criteria, 
respectively, was observed with RPCph. A corresponding passing rate of 
93.5±5.4%, 98.9±1.5% and 99.4±1.2% for 3%/3 mm, 5%/5 mm and 
7%/4mm QA criteria , respectively, was observed with the VPP using 
Instph data. 
Conclusions: IMRT credentialing for H&N prospective trials using 
institutional phantom measurements is possible and was successful in 
all cases using the RPC passing criteria.  
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Purpose/Objective: Techniques in radiotherapy that account for the 
effects of motion of the target tissue, have gained increasing 
importance in both research and clinical practice. Validation of these 
techniques requires robotic phantoms, which represent structure, 
physical properties and motion of a human body environment and 
allow dose measurement. Such phantom was recently developed by 
our group. It allows generation respectively reproduction of previously 
recorded patient motion in all translational degrees of freedom with 
sub-millimeter precision while featuring a realistic structural design, 
which involves the relative motion of an inside tumour with respect to 
a static environment as well as an extensive modularization of tissue 
equivalent components and dosage measurement devices. The 
objective of this work is to evaluate the applicability of the novel 
robotic phantom in clinical practice of quality insurance of 
radiotherapy and assess the phantom’s potentials. 
Materials and Methods: A solid perplex sphere, encased by a layer of 
wood was used to resemble the tissues of the target of dose 
application and the surrounding lung. Radiochromic films, placed in 
five cutting planes of the sphere, were used for dose measurements. 
The sphere was attached to a flange moving in a water environment. 
Irradiation with different field forms was applied on the robotic 
phantom, first, with its actuators blocked, then, with concurrent 
playback of respiratory motion. Dose distributions measured and 
calculated by the treatment planning system (TPS) were compared. 
Results: Application of the phantom in both medical imaging and 
radiotherapy and obtained results have proven feasible. The 
construction turned out not to cause any noticable distortions, e.g. as 
a result of the robotic components of the phantom. In static case, 
measured and calculated dose distributions were compared with 
Gamma Index criteria (3mm/3%). All evaluated films agreed with the 
calculated dose distribution with an accordance above 99%. Dose 
distributions measured with the moving phantom showed typical dose 
blurring. The system components of the robotic phantom and test 
results are depicted in the figure. 
 
  
Conclusions: Suitability of the physical properties of the robotic 
phantom, applicability in clinical practice and capability of validation 
of the process chain of radiotherapy in the presence of motion with a 
realistic setup and test scenario were successfully proven. The new 
features of the robotic phantom, e.g. the uniquely high 
customizability of both motion and structure of the human body 
replication will allow the effects of motion to be comprehensively 
investigated and techniques of motion compensation to be improved 
in the future. 
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Purpose/Objective: The increasing complexity of radiotherapy (RT) 
has motivated research into three dimensional (3D) dosimetry. In this 
study we investigate the use of 3D dosimetry with polymerizing gels 
and optical computed tomography (optical CT) as a verification tool 
for complex RT: dose painting, and target tracking. 
Materials and Methods: For the dose painting studies, two dosimeters 
were irradiated with a 7-field intensity modulated radiotherapy (IMRT) 
plan with and without dose prescription based on a hypoxia image 
dataset of a head and neck patient. In the tracking experiments, two 
dosimeters were irradiated with a volumetric modulated arc therapy 
(VMAT) plan with and without clinically measured prostate motion and 
a third with both motion and target tracking. To assess the 
performance, 3D gamma analyses were performed between measured 
and calculated stationary dose distributions. 
Results: Gamma pass-rates of 95.3 % and 97.3 % (figure 1) were 
achieved for the standard and dose-painted IMRT plans. Gamma pass-
rates of 91.4 % and 54.4 % were obtained for the stationary and 
moving dosimeter, respectively, while tracking increased the pass-
rate for the moving dosimeter to 90.4 %. 
 
 
Conclusions: This study has shown that the 3D dosimetry system can 
reproduce and thus verify complex dose distributions, also when 
influenced by motion. 
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Purpose/Objective: In dose-guided radiotherapy, delivered fluence 
may be adapted based on the actual delivered patient dose in 
previous fractions, as derived from in-room acquired cone-beam CTs 
(CBCTs) and electronic portal images (EPIs).In our institute, EPIs are 
converted into absolute portal dose images (PDIs), and compared to 
PDI predictions to assess the actual delivered 2D fluence profiles. PDI 
predictions are based on segment shapes and MUs stored in the linac 
R&V system and the fraction CBCT. Estimated actual delivered 
fluences and the CBCT might then be used to reconstruct the 
delivered 3D patient dose in a fraction. In case of intra-fraction 
anatomy changes, the CBCT may not accurately represent the patient 
anatomy for all treatment beams, yielding inaccuracies in 
reconstructed patient dose. Here we will focus on the impact of intra-
fraction motion on the accuracy of estimated fluence profiles used in 
the patient dose reconstruction.  
Materials and Methods: For 50 prostate cancer patients treated with 
5-7 IMRT fields, CBCTs and EPIs were acquired in 4-5 fractions. PDIs 
derived from EPIs were compared to predictions based on the CBCT. 
To accurately predict beam transmission, Hounsfield units from the 
planning CT-scan were mapped onto the CBCT while accounting for 
the patient’s non-rigid anatomy, using our previously published 
algorithm. Predictions also accounted for treatment couch absorption, 
using our recently published couch model. As benchmark, measured 
and predicted PDIs were also compared for an anatomical phantom, 
irradiated with the plans of 10 patients. Gamma-analyses with 3% 
global dose difference and 3 mm distance to agreement as reference 
criteria were performed. Combination of fractions was evaluated to 
enhance the accuracy of estimated delivered fluence profiles.  
Results: For the phantom, the average percentage of rejected pixels 
in PDIs was 0.8±0.7% (1SD). For the 1413 evaluated patient fields this 
increased to 1.4 ± 2.8%. The increase could partially be attributed to 
intra-fraction anatomy changes. Due to these changes, the acquired 
CBCT was not fully representative for all fields. For some fractions 
this resulted in large differences between fields in agreement 
between measured and predicted PDI. Combination of the first 2 
fractions yielded results in close agreement with the phantom 
(average percentage of rejected pixels: 0.6 ±3.4%).The agreement 
